Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas. Show more
21 Waterway Avenue, The Woodlands, TX, 77380, United States
Market Cap
4.243M
52 Wk Range
$2.44 - $32.55
Previous Close
$4.37
Open
$4.30
Volume
51,898
Day Range
$4.23 - $4.42
Enterprise Value
-6.428M
Cash
3.46M
Avg Qtr Burn
-3.544M
Insider Ownership
3.87%
Institutional Own.
2.88%
Qtr Updated
06/30/26
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
